Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (22)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Remy, B
Right arrow Articles by Lamy, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Remy, B
Right arrow Articles by Lamy, M
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Medical Bulletin 55:277-298 (1999)
© 1999 The British Council

research-article

Red blood cell substitutes: fluorocarbon emulsions and haemoglobin solutions

B Remy*,, G Deby-Dupont*,{dagger} and M Lamy*,{dagger}

*Department of Anaesthesia and Intensive Care Medicine Liège, Beligum
{dagger}Centre for Oxygen Research and Development, University of Liège Liège, Belgium

Correspondence to: Dr Bernadette Remy, Department of Anaesthesia and Intensive Care Medicine, University Hospital, B35, Domaine universitaire du Sart Tilman, B–4000 Liège, Belgium

Abstract

The problems posed by transfusion of homologous blood have led to the development of substances able to replace the gas transporting properties of blood. Perfluorocarbons (PFCs) emulsions and modified haemoglobin (Hb) solutions have been developed for this goal and are now tested in clinical assays.

PFCs are synthetic fluorinated hydrocarbons, capable of dissolving large quantities of oxygen (O2; without binding) at high inspired concentrations of O2 and of delivering this O2 to the tissues. They are administered as emulsions containing particles with a diameter of approximately 0.2 µm, capable of entering the microcirculation. They are eliminated unchanged by the lungs within several days. Fluosol-DA* 20% was the first PFC emulsion used in clinical practice. Currently, OxygentTM, a second generation PFC emulsion, is being evaluated in clinical studies. The PFCs are not blood substitutes, but rather a means to ensure tissue oxygenation during extreme haemodilution.

Solutions of free Hb do not have the antigenic characteristics of the blood groups, and do not require compatibility testing. They are fully saturated with O2 at ambient FiO2. The Hbs used are derived from either human or bovine sources, or via recombinant DNA technology. In order to maintain satisfactory intravascular half-life and O2 affinity, the Hb molecules are modified by adding internal crosslinks, by polymerization, and/or by encapsulation. After promising animal studies, several of these modified Hb solutions are now being studied in Phase III clinical trials. Among them, diaspirin cross-linked haemoglobin (DCLHb) has been used in cardiac and orthopaedic surgery, and for resuscitation of traffic accident victims. The initial results of multicentre trials are now being analysed.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Appl. Physiol.Home page
L. A. Vane, J. S. Funston, R. Kirschner, D. Harper, D. J. Deyo, D. L. Traber, L. L. Traber, and G. C. Kramer
Comparison of transfusion with DCLHb or pRBCs for treatment of intraoperative anemia in sheep
J Appl Physiol, January 1, 2002; 92(1): 343 - 353.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.